Faiz Anwer

4.4k total citations · 1 hit paper
328 papers, 2.5k citations indexed

About

Faiz Anwer is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Faiz Anwer has authored 328 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Hematology, 142 papers in Oncology and 87 papers in Molecular Biology. Recurrent topics in Faiz Anwer's work include Multiple Myeloma Research and Treatments (111 papers), CAR-T cell therapy research (60 papers) and Chronic Lymphocytic Leukemia Research (45 papers). Faiz Anwer is often cited by papers focused on Multiple Myeloma Research and Treatments (111 papers), CAR-T cell therapy research (60 papers) and Chronic Lymphocytic Leukemia Research (45 papers). Faiz Anwer collaborates with scholars based in United States, Pakistan and India. Faiz Anwer's co-authors include Ali McBride, Irbaz Bin Riaz, Jennifer S. Carew, Ahmad Iftikhar, Umar Zahid, Daniel O. Persky, Jason Valent, Atlantis Dawn Russ, Jack Khouri and Steffan T. Nawrocki and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Faiz Anwer

285 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results

2023 168 citations Faiz Anwer, Shaji Kumar et al. profile →

Peers

Countries citing papers authored by Faiz Anwer

Since Specialization

Citations

This map shows the geographic impact of Faiz Anwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faiz Anwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faiz Anwer more than expected).

Fields of papers citing papers by Faiz Anwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faiz Anwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faiz Anwer. The network helps show where Faiz Anwer may publish in the future.

Co-authorship network of co-authors of Faiz Anwer

This figure shows the co-authorship network connecting the top 25 collaborators of Faiz Anwer. A scholar is included among the top collaborators of Faiz Anwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faiz Anwer. Faiz Anwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists 2025 ·JAMA Network Open ·(unknown), (unknown), (unknown), David C. Kaelber, Faiz Anwer, Abhay Singh	4
2	Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma 2024 ·Transplantation and Cellular Therapy ·James A. Davis, Danai Dima, Nausheen Ahmed, (unknown), Joseph P. McGuirk, Jack Khouri, Jason Valent, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi	1
3	Impact of T-Cell Redirecting Therapies on Survival Outcomes in Ultra-High-Risk Multiple Myeloma and Plasma Cell Leukemia 2024 ·Blood ·(unknown), (unknown), Shahzad Raza, (unknown), Christy Samaras, Beth Faiman, Jack Khouri, Jason Valent, Faiz Anwer, Louis Williams	1
4	Yield of repeat blood cultures in acute myeloid leukemia patients with febrile neutropenia and bacteremia following allogeneic hematopoietic stem cell transplant 2024 ·Transplant Infectious Disease ·(unknown), (unknown), (unknown), Meera Patel, (unknown), (unknown), Faiz Anwer, (unknown)	1
5	A Pilot Study Assessing the Accuracy of AI ChatGPT Responses for AL Amyloidosis 2024 ·European Journal Of Haematology ·(unknown), Raymond L. Comenzo, Jack Khouri, Faiz Anwer, Heather Landau, Chakra P. Chaulagain	0
6	Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities 2024 ·JCO Oncology Practice ·Hamlet Gasoyan, Faiz Anwer, (unknown), (unknown), Jason Valent, Ming Wang, Michael T. Halpern, Michael B. Rothberg	2
7	TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians 2024 ·Transplantation and Cellular Therapy ·(unknown), Nausheen Ahmed, (unknown), (unknown), (unknown), Anuj Shrestha, Faiz Anwer, Zahra Mahmoudjafari, (unknown), Hamza Hashmi, Siddhartha Ganguly, Joseph P. McGuirk, Shebli Atrash, (unknown), Rahul Banerjee, (unknown)	2
8	Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma 2023 ·Transplantation and Cellular Therapy ·James A. Davis, Danai Dima, Nausheen Ahmed, (unknown), Joseph P. McGuirk, Xuefei Jia, Shahzad Raza, Jack Khouri, Jason Valent, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi	18
9	External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs 2023 ·British Journal of Haematology ·Danai Dima, Ang Li, (unknown), (unknown), (unknown), (unknown), Saeid Mirzai, Wei Wei, Christy Samaras, Jason Valent, Faiz Anwer, Jack Khouri	7
10	Cancer Survivorship in Gulf Countries: An Updated Systematic Review 2023 ·Blood ·Maha Hameed, (unknown), (unknown), (unknown), (unknown), Asad Amin, (unknown), Faiz Anwer, Muhammad Salman Faisal	0
11	Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma 2023 ·Blood ·James A. Davis, Danai Dima, Nausheen Ahmed, (unknown), Joseph P. McGuirk, Jack Khouri, Jason Valent, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi	2
12	Efficacy and tolerability of isocitrate dehydrogenase inhibitors in patients with acute myeloid leukemia: A systematic review of clinical trials 2023 ·Leukemia Research ·Wajeeha Aiman, Muhammad Ashar Ali, Muhammad Abdul Basit, (unknown), Muhammad Suleman, Muhammad Hassan, (unknown), (unknown), (unknown), (unknown), Muhammad Salman Faisal, Michael J. Akerman, (unknown), Faiz Anwer	10
13	Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study 2021 ·British Journal of Haematology ·Fahrettin Covut, (unknown), Sanchit Chawla, (unknown), Christy Samaras, Faiz Anwer, Alex Garcia, Dana E. Angelini, (unknown), Beth Faiman, Jason Valent, Jack Khouri	25
14	Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel 2021 ·Transplantation and Cellular Therapy ·Agrima Mian, Wei Wei, Brian T. Hill, Betty K. Hamilton, Brad Pohlman, Deepa Jagadeesh, Faiz Anwer, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Navneet S. Majhail	2
15	Comparison of the Prognostic Value of Risk Assessment Tools in Allogeneic Hematopoietic Cell Transplantation 2021 ·Transplantation and Cellular Therapy ·(unknown), Lisa Rybicki, (unknown), (unknown), Faiz Anwer, Robert M. Dean, Brian T. Hill, Matt Kalaycio, Jack Khouri, Deepa Jagadeesh, Brad Pohlman, Ronald Sobecks, Allison Winter, Navneet S. Majhail, Betty K. Hamilton	1
16	Chronic Iron Deficiency 2021 ·StatPearls ·(unknown), Faiz Anwer	2
17	Vaccine responses in patients with chronic lymphocytic leukemia on treatment with Bruton Tyrosine Kinase Inhibitors: a focused review 2021 ·Hematology Transfusion and Cell Therapy ·(unknown), (unknown), Faiz Anwer	4
18	The Impact of Atrial Fibrillation on hospitalization Outcomes for Patients With Chronic Lymphocytic Leukemia Using the National Inpatient Sample Database 2021 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Samarthkumar Thakkar, Harsh Patel, (unknown), Syed Ather Hussain, (unknown), (unknown), Sourbha S. Dani, Sarju Ganatra, Faiz Anwer	7
19	Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis 2020 ·Cancer ·Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, (unknown), (unknown), Faiz Anwer, Alok A. Khorana, S. Vincent Rajkumar, Shaji Kumar, M. Hassan Murad, Zhen Wang, Safi U. Khan, Navneet S. Majhail	31
20	Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis 2019 ·Blood ·Agrima Mian, Wei Wei, Allison Winter, Jack Khouri, Deepa Jagadeesh, Faiz Anwer, Aaron T. Gerds, Robert M. Dean, Ronald Sobecks, Brad Pohlman, Matt Kalaycio, Betty K. Hamilton, Navneet S. Majhail, Brian T. Hill	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact